Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn2r32 Activators

Vmn2r32 activators are a class of chemicals that can modulate the function of the vomeronasal type 2 receptor 32 (Vmn2r32), a G protein-coupled receptor (GPCR) implicated in chemosensory signaling. These activators can engage with the Vmn2r32 or its associated signaling pathways, leading to an alteration in receptor activity. The class includes various molecules that can enhance intracellular second messenger concentrations, such as cyclic adenosine monophosphate (cAMP), or influence the activity of downstream kinases like protein kinase A (PKA). Activators within this class can exert their effects by either direct interaction with the receptor or through modulation of the receptor's signaling cascade. For instance, compounds that increase the intracellular levels of cAMP can activate PKA, which in turn can phosphorylate the GPCR, resulting in a change in the receptor's activity.

The signaling mechanisms utilized by Vmn2r32 activators are diverse, encompassing various biochemical pathways that facilitate GPCR signaling. Some activators work by inhibiting the enzymatic breakdown of second messengers, thereby sustaining or amplifying the receptor signal. Others act as ionophores, altering the intracellular concentration of ions such as calcium, which serves as a crucial signaling molecule in GPCR pathways. Additionally, there are activators that can influence the function of other enzymes like phospholipase C or kinases that are integral to the signaling network of GPCRs. By modulating these enzymes, Vmn2r32 activators can indirectly affect the receptor's activity. It is through such intricate interactions within the cellular signaling framework that these chemicals can modulate the function of Vmn2r32, leading to an alteration in its signaling output.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-specific inhibitor of phosphodiesterases, which prevents cAMP breakdown, thus enhancing GPCR signaling which could possibly activate Vmn2r32.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C (PKC) which can phosphorylate GPCRs and regulate their function, which could possibly activate Vmn2r32 signaling.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Calcium ionophore that increases intracellular calcium levels, which could possibly activate GPCR signaling, including Vmn2r32.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Catalyzes ADP-ribosylation of Gi alpha proteins, inhibiting their activity and thus could possibly modify GPCR signaling, including Vmn2r32.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

Inhibitor of Ca2+/calmodulin-dependent protein kinase II, which could possibly affect GPCR signaling including Vmn2r32.

Nitrendipine

39562-70-4sc-201466
sc-201466A
sc-201466B
50 mg
100 mg
500 mg
$109.00
$160.00
$458.00
6
(1)

Calcium channel blocker that can alter calcium influx, affecting GPCR signaling pathways which could possibly include Vmn2r32.

Carbachol

51-83-2sc-202092
sc-202092A
sc-202092C
sc-202092D
sc-202092B
sc-202092E
1 g
10 g
25 g
50 g
100 g
250 g
$122.00
$281.00
$388.00
$683.00
$1428.00
$3060.00
12
(2)

Cholinergic agonist that activates phospholipase C through Gq protein-coupled receptors, potentially influencing GPCR signaling which could possibly activate Vmn2r32.